Avalo Therapeutics (AVTX)
(Delayed Data from NSDQ)
$7.00 USD
-2.05 (-22.65%)
Updated Aug 30, 2024 03:59 PM ET
Pre-Market: $7.70 +0.70 (10.00%) 8:14 AM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-1.45 | 0.00% |
Earnings Summary
For their last quarter, Avalo Therapeutics (AVTX) reported earnings of -$14.07 per share, missing the Zacks Consensus Estimate of -$6.70 per share. This reflects a negative earnings surprise of 110.00%. Look out for AVTX's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$1.45 per share, reflecting a year-over-year increase of 94.46%.
Earnings History
Price & Consensus
Zacks News for AVTX
Is Avalo Therapeutics (AVTX) Stock Outpacing Its Medical Peers This Year?
AVTX: What are Zacks experts saying now?
Zacks Private Portfolio Services